BSE NSE
Your Result on : Company News Details
Advanced Enzyme Technologies Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
540025
ISIN Demat
INE837H01020
Book Value (Rs)
56.2513194
NSE Symbol
ADVENZYMES
Divident Yield %
1.54
Market Cap
(Rs In Cr.)
3,766
P/E (TTM)
36.79
EPS (TTM)
9.15
Face Value
(Rs)
2
Back
Advanced Enzyme Technologies consolidated net profit declines 6.46% in the March 2025 quarter
13-May-25   Hrs IST

Net profit of Advanced Enzyme Technologies declined 6.46% to Rs 26.48 crore in the quarter ended March 2025 as against Rs 28.31 crore during the previous quarter ended March 2024. Sales rose 5.93% to Rs 167.18 crore in the quarter ended March 2025 as against Rs 157.82 crore during the previous quarter ended March 2024.

For the full year,net profit declined 1.64% to Rs 131.12 crore in the year ended March 2025 as against Rs 133.31 crore during the previous year ended March 2024. Sales rose 2.09% to Rs 636.91 crore in the year ended March 2025 as against Rs 623.87 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales167.18157.82 6 636.91623.87 2
OPM %27.2835.08 -30.5332.77 -
PBDT53.5464.02 -16 223.92238.19 -6
PBT43.4654.74 -21 187.36202.95 -8
NP26.4828.31 -6 131.12133.31 -2

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)